Table 4.

Bivariate analysis of variables collected during the ICU stay influencing the outcome, at ICU discharge, of pneumococcal CAP*

Variables	Survivors n = 44	Non survivors n = 26	p
Use of hydrocortisone	12 (27.3%)	12 (46.2%)	0.1
Intensive insulin therapy	18 (40.9%)	12 (46.2%)	0.66
Haemodialysis	6 (13.6%)	4 (15.4%)	0.1
Improvement on D3	36 (81.8%)	7 (26.9%)	<0.0001
SOFA >8 on D3	9 (20.5%)	14 (53.8%)	<0.0001
SOFA >8 on D5	10 (22.7%)	14 (53.8%)	0.0001
SOFA >8 on D7	10 (22.7%)	13 (50%)	0.009
Sepsis-related complications	14 (31.8%)	17 (65.4%)	0.006
HA-LRT superinfections	8 (18.2%)	9 (34.6%)	0.12

*Data are presented as No. (%)

SOFA: Sepsis-related Organ Failure Assessment score; HA-LRT superinfections: hospital-acquired lower respiratory tract superinfections.